MedTrace Logo

Canola Oil Multicentre Intervention Trial (COMIT)

NCT01233778 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2023-08-21

No results posted yet for this study

Summary

The objectives of this study are to examine how the consumption of treatment oils (including canola oil, DHA enriched canola-oil, high oleic acid canola oil, flax oil, and safflower oil) influence endothelial function, inflammation, oxidation, body composition, and plasma lipoprotein characterization.

Conditions

Interventions

DIETARY_SUPPLEMENT

Canola Oil

60g Canola oil daily per 3000kcal diet provided in a supplemental shake

DIETARY_SUPPLEMENT

High Oleic Acid + DHA Canola Oil

60g high oleic acid canola oil + DHA daily per 3000kcal provided in a supplemental shake

DIETARY_SUPPLEMENT

High Oleic Acid Canola Oil

60g high oleic acid canola oil daily per 3000kcal provided in a supplemental shake

DIETARY_SUPPLEMENT

Flax Oil

36g flax oil + 24g safflower oil daily per 3000kcal provided in a supplemental shake

DIETARY_SUPPLEMENT

Safflower Oil

45g safflower oil + 15g corn oil daily per 3000kcal provided in a supplemental shake

Sponsors & Collaborators

  • University of Manitoba

    collaborator OTHER

  • Penn State University

    lead OTHER

Principal Investigators

  • Penny M Kris-Etherton, PhD, RD · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2012-03-31
Completion
2012-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01233778 on ClinicalTrials.gov